2DG covid medicine
<p>
<iframe allow="accelerometer; autoplay; clipboard-write; encrypted-media; gyroscope; picture-in-picture" allowfullscreen="" frameborder="0" height="315" src="https://www.youtube.com/embed/D5hHAoYVoAM" title="YouTube video player" width="560"></iframe></p>
<p>
Defence Research and Development Organisation (DRDO) developed anti-Covid oral drug laboratory has been granted emergency use approval by the Drug Controller General of India (DCGI). Called as the 2-deoxy-D-glucose (2-DG), the oral drug is developed by Institute of Nuclear Medicine and Allied Sciences (INMAS) in collaboration with Dr Reddy&#39;s Laboratories. It will be used as an adjunct therapy in moderate cases of hospitalised COVID19 patients to reduce their supplemental oxygen dependence. Here&#39;s all you need to know about it!</p>
Prime Minister Narendra Modi on Monday, thanked Brazilian President Lula da Silva for the warm…
Union Minister of Ports, Shipping and Waterways, Sarbananda Sonowal, had a bilateral meeting with his…
External Affairs Minister S Jaishankar said on Monday that conferment of Nigeria's national award 'Grand…
Russia has strongly condemned outgoing US President Joe Biden's decision allowing Ukraine to strike deep…
In Pakistan-occupied Jammu and Kashmir (PoJK), an alarming environmental crisis is rapidly unfolding. Once home…
In a significant show of commitment to enhancing bilateral relations, Catherine West, the UK Minister…